Rigshospitalet, University of Copenhagen
Department of Clinical Biochemistry
MD PhD finished Medical school at University of Copenhagen in 2017. Published 6 original articles in high-impact peer-reviewed journals as first author during Medical School within the research field of genetic and lifestyle risk factors for dementia and cardiovascular disease. Had one year of clinical medical training (internship) from 2017-2018 in a cardiovascular disease departmemt in Copenhagen, Bispebjerg hospital and in general practice. Defended my PhD-thesis at the departmemt of Clinical Biochemstry at Rigshospitalet, Copenhagen University Hospital within the research field of genetic and lifestyle risk factors for dementia and cardiovascular disease in January 2022. Currently working as a medical doctor at the departmemt of Clinical Biochemstry at Rigshospitalet, Copenhagen, Denmark.

Presenter of 1 Presentation

BODY MASS INDEX AND RISK OF DEMENTIA

Session Type
Workshop - Risk factors
Date
Wed, 25.05.2022
Session Time
11:00 - 12:30
Room
Rodolfo Paoletti - Red room
Lecture Time
12:10 - 12:20

Abstract

Background and Aims

Midlife obesity and underweight in the elderly have been associated with a high risk of dementia. However, the association between body mass (BMI) and risk of dementia depends on the type of dementia investigated. Whether there is a causal association between BMI and the vascular part of dementia called “non-Alzheimer dementia” remains unknown. We aimed to investigate the association between BMI and risk of “non-Alzheimer dementia”, Alzheimer’s disease, and all-cause dementia.

Methods

In a prospective cohort of the Danish general population including 95,000 individuals we investigated the observational and genetically determined association between BMI and risk of “non-Alzheimer dementia”, Alzheimer’s disease, and all-cause dementia. For the genetic analyses we created a weighted allele score and divided it into four groups from lowest to highest BMI.

Results

The observational association between BMI and risk of “non-Alzheimer dementia” and all-cause dementia was u-shaped with nadir at a BMI of 26 kg/m2. For Alzheimer’s disease the association was linear with low BMI associated with high risk. Comparing the group with the lowest genetically determined BMI to the group with the highest genetically determined BMI the hazard ratio (95% confidence interval) was 1.22 (1.01- 1.47) for “non-Alzheimer dementia”, 1.04 (0.90-1.20) for Alzheimer’s disease, and 1.10 (0.98-1.23) for all-cause dementia.

Conclusions

Genetically determined high BMI is associated with high risk of the vascular part of dementia in the general population. BMI is thus a potentially modifiable risk factor for dementia that could be targeted in the strive to prevent this devastating disease.

Hide